Company intelligence / Profile preview

Shanghai Sine Pharmaceutical Laboratories

Shanghai, Shanghai, Chinasinepharmaeurope.com ↗

Ownership: Private
Development stage: Commercial

Overview

Shanghai Sine Pharmaceutical is an established pharmaceutical manufacturer with commercialized small molecule drugs and biological products across several therapeutic areas. Its portfolio includes approved therapies for gastrointestinal disorders, infectious disease, oncology, metabolic disease, among others. The company is also active in supplying APIs globally.

Therapeutic areas: OncologyEndocrinologyImmunologyGastroenterologyNeurologyInfectious Diseases
Modalities: Small moleculeBiological productsLive biotherapeutic products
Industry: Biotech

Drug pipeline

3 assets

WST04

Unknown

2 more assets in the full pipeline.

Request access →

Beyond the preview

Go deeper on Shanghai Sine Pharmaceutical Laboratories.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Shanghai Sine Pharmaceutical Laboratories.

Explore the full profile